Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07589634 |
| Title | A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma (TRI Pro) |
| Acronym | TRI Pro |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Janssen Research & Development, LLC |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Beverly Hills Cancer Center (BHCC) | RECRUITING | Beverly Hills | California | 90211 | United States | Details |
| Hospital Ampang | RECRUITING | Ampang | 68000 | Malaysia | Details | |
| Hospital Sultanah Aminah | RECRUITING | Johor Bharu | 80100 | Malaysia | Details | |
| Sarawak General Hospital | RECRUITING | Kuching | 93586 | Malaysia | Details |